| Univariate | Multivariate | ||||||
---|---|---|---|---|---|---|---|---|
n | βa | 95 % CIb | p | n | βc | 95 % CIb | p | |
BMI (kg/m2) | 46 | 0.17 | −0.39 ~ 1.39 | 0.27d |  |  |  |  |
Gender (Male = 1, Female = 2) | 47 | −0.13 | −11.5 ~ 4.59 | 0.39 |  |  |  |  |
Age (year) | 47 | −0.24 | −0.72 ~ 0.06 | <0. 1 | 44 | −0.07 | −0.55 ~ 0.38 | 0.7 |
Body weight (kg) | 47 | 0.3 | 0.02 ~ 0.52 | 0.04 | 44 | 0.07 | −0.24 ~ 0.36 | 0.68 |
Abdominal girth (cm) | 45 | 0.11 | −0.28 ~ 0.59 | 0.47 |  |  |  |  |
HbA1c (%) | 47 | 0.08 | −3.57 ~ 6.38 | 0.57 |  |  |  |  |
Uric acid (mg/dL) | 47 | 0.05 | −2.3 ~ 3.26 | 0.74 |  |  |  |  |
TC (mg/dL) | 47 | −0.37 | −0.29 ~ −0.04 | 0.011 | 44 | -0.39 | −0.30 ~ −0.05 | 0.009 |
LDL-C (mg/dL) | 47 | −0.21 | −0.22 ~ 0.04 | 0.15e |  |  |  |  |
TG (mg/dL) | 47 | −0.1 | −0.07 ~ 0.04 | 0.5 |  |  |  |  |
HDL-C (mg/dL) | 47 | −0.32 | −0.56 ~ −0.03 | 0.03 | 44 | −0.16 | −0.42 ~ 0.13 | 0.29 |
sd LDL-C (mg/dL) | 47 | −0.29 | −0.43 ~ 0.01 | 0.04e |  |  |  |  |
ApoA-I (mg/dL) | 47 | −0.28 | −0.29 ~ 0.003 | 0.05f |  |  |  |  |
CETP (μg/mL) | 44 | 0.38 | 2.09 ~ 15.69 | 0.01 | 44 | 0.41 | 2.91 ~ 16.5 | 0.006 |
Pioglitazone use | 47 | −0.02 | −12.1 ~ 10.63 | 0.9 |  |  |  |  |
Change in Body weight (%) | 47 | 0.19 | −0.57 ~ 2.66 | 0.2 | 43 | 0.36 | 0.44 ~ 3.64 | 0.01 |
Change in HbA1c (%) | 47 | −0.009 | −0.56 ~ 0.52 | 0.95 |  |  |  |  |
Change in Uric acid (%) | 47 | 0.14 | −0.15 ~ 0.43 | 0.33 |  |  |  |  |
Change in TG (%) | 46 | 0.22 | −0.02 ~ 0.12 | 0.15 | 43 | 0.17 | −0.02 ~ 0.10 | 0.2 |
Change in HDL-C (%) | 47 | −0.07 | −0.47 ~ 0.29 | 0.64 |  |  |  |  |
Change in ApoA-I (%) | 46 | 0.06 | −0.48 ~ 0.71 | 0.71 |  |  |  |  |
Change in CETP (%) | 44 | 0.44 | 0.12 ~ 0.52 | 0.003 | 43 | 0.57 | 0.21 ~ 0.60 | 0.0001 |